Considerable pro-inflammatory cytokines, including tumor necrosis factor (TNF)-α, type I interferon (IFN), and notably interleukin (IL)-17/23, emanating from cutaneous lesions in psoriasis patients, elicit an aberrant immune response within the pulmonary system via the circulatory system. The gene discussed is IFNA1; the disease is psoriasis.